Related Experiment Video
Updated: Dec 24, 2025

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
Anticancer Mechanisms of Bioactive Peptides
Tsuey Ning Soon1, Adeline Yoke Yin Chia1, Wei Hsum Yap1
1School of Biosciences, Faculty of Medical and Health Sciences, Taylor's University, 47500 Subang Jaya, Selangor Darul Ehsan, Malaysia.
Abstract:
Despite technological advancement, there is no 100% effective treatment against metastatic cancer. Increasing resistance of cancer cells towards chemotherapeutic drugs along with detrimental side effects remained a concern. Thus, the urgency in developing new anticancer agents has been raised. Anticancer peptides have been proven to display potent activity against a wide variety of cancer cells. Several mode of actions describing their cytostatic and cytotoxic effect on cancer cells have been proposed which involves cell surface binding leading to membranolysis or internalization to reach their intracellular target. Understanding the mechanism of action of these anticancer peptides is important in achieving full therapeutic success. In the present article, we discuss the anticancer action of peptides accompanied by the mechanisms underpinning their toxicity to cancer cells.
Insights
Anticancer peptides show potent activity against various cancer cells, offering a promising alternative to traditional chemotherapy. Understanding their mechanisms of action is crucial for developing effective cancer treatments.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Metastatic cancer treatment remains a challenge due to drug resistance and side effects.
- There is a critical need for novel anticancer agents.
- Anticancer peptides (ACPs) are emerging as potent therapeutic candidates.
Purpose of the Study:
- To review the anticancer actions of peptides.
- To elucidate the mechanisms underlying their toxicity to cancer cells.
Main Methods:
- Literature review of studies on anticancer peptides.
- Analysis of proposed mechanisms of action, including cell surface binding, membranolysis, and intracellular targeting.
Main Results:
- Anticancer peptides exhibit broad-spectrum activity against diverse cancer cell types.
- Mechanisms include disruption of cancer cell membranes and interference with intracellular processes.
- ACPs demonstrate both cytostatic and cytotoxic effects.
Conclusions:
- Anticancer peptides represent a promising therapeutic strategy for cancer treatment.
- Further research into their mechanisms of action will optimize their clinical application.
- Understanding ACPs' toxicity mechanisms is key to maximizing therapeutic success.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy

